On November 11, Palantir rose 3.42% in Regular Trading, trading around $171.505 per share, with turnover of about $550 million.

The move coincided with continued digestion of bullish external signals, including a newly launched Buy rating with a $200 price target and a large bullish options trade tied to 2027 $190 calls.

Additional context showed consensus analyst price target estimates near $222.45, while options flow included about $10.9 million in long-dated call activity and a Call/Put volume ratio of 1.87, indicating stronger call participation than put activity. Recent supportive backdrop also included target price increases from several brokerages and business expansion updates tied to NHS contract developments and broader AI deployment efforts.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)